APP and Alzheimer disease: The discovery of genetic mutations associated with AD that occur in presenilin 1 and presenilin 2 (PSEN1 and PSEN2) supports this hypothesis and gives rise to alterations in the proteolytic processing of amyloid precursor protein (APP), with consequent overexpression of abnormal Aβ species.